Stephen Gucker

Array ( [id] => 6616891 [patent_doc_number] => 20020064833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Recombinant plasmids and method for treating substance abuse' [patent_app_type] => new [patent_app_number] => 09/960288 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1649 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064833.pdf [firstpage_image] =>[orig_patent_app_number] => 09960288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016851 [patent_doc_number] => 20020103123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)' [patent_app_type] => new [patent_app_number] => 09/962646 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 40859 [patent_no_of_claims] => 175 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103123.pdf [firstpage_image] =>[orig_patent_app_number] => 09962646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720826 [patent_doc_number] => 20030054514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Novel polynucleotides and proteins encoded thereby' [patent_app_type] => new [patent_app_number] => 09/957187 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 59418 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054514.pdf [firstpage_image] =>[orig_patent_app_number] => 09957187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813611 [patent_doc_number] => 20030073161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Variant human alpha7 acetylcholine receptor subunit, and methods of production and use thereof' [patent_app_type] => new [patent_app_number] => 09/954936 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13003 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073161.pdf [firstpage_image] =>[orig_patent_app_number] => 09954936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451372 [patent_doc_number] => 06455687 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Human lactoferrin' [patent_app_type] => B1 [patent_app_number] => 09/932190 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11715 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455687.pdf [firstpage_image] =>[orig_patent_app_number] => 09932190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101908 [patent_doc_number] => 06815418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'TGF- polypeptides, functional fragments and methods of use therefor' [patent_app_type] => B2 [patent_app_number] => 09/932172 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 23238 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815418.pdf [firstpage_image] =>[orig_patent_app_number] => 09932172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082306 [patent_doc_number] => 20020082213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Method of identifying compounds having antiepileptic, anticonvulsant or anxiolytic activities' [patent_app_type] => new [patent_app_number] => 09/929986 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6375 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082213.pdf [firstpage_image] =>[orig_patent_app_number] => 09929986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6673831 [patent_doc_number] => 20030059434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Methods and compositions for treating gastrointestinal tract mucin production associated disease conditions' [patent_app_type] => new [patent_app_number] => 09/925547 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15171 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059434.pdf [firstpage_image] =>[orig_patent_app_number] => 09925547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326201 [patent_doc_number] => 06599695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => 'Method for assaying for early gene expression in neuroblasts' [patent_app_type] => B2 [patent_app_number] => 09/915229 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 13848 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599695.pdf [firstpage_image] =>[orig_patent_app_number] => 09915229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473046 [patent_doc_number] => 20020151483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'C3b/C4b complement receptor-like molecules and uses thereof' [patent_app_type] => new [patent_app_number] => 09/911842 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29427 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151483.pdf [firstpage_image] =>[orig_patent_app_number] => 09911842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982197 [patent_doc_number] => 06927041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Human neuropeptide Y-like G protein-coupled receptor' [patent_app_type] => utility [patent_app_number] => 09/899532 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 25196 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927041.pdf [firstpage_image] =>[orig_patent_app_number] => 09899532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015876 [patent_doc_number] => 20020102653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'DNA coding for human cell surface antigen' [patent_app_type] => new [patent_app_number] => 09/884987 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10588 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102653.pdf [firstpage_image] =>[orig_patent_app_number] => 09884987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032131 [patent_doc_number] => 20020018799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Collagen tubes for nerve regeneration' [patent_app_type] => new [patent_app_number] => 09/885537 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1919 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018799.pdf [firstpage_image] =>[orig_patent_app_number] => 09885537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096551 [patent_doc_number] => 20020052313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Nerve growth factor as a vaccine adjuvant' [patent_app_type] => new [patent_app_number] => 09/928698 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10456 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052313.pdf [firstpage_image] =>[orig_patent_app_number] => 09928698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242193 [patent_doc_number] => 20020045216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Mouse G protein coupled receptor FMRL-3' [patent_app_type] => new [patent_app_number] => 09/879017 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11742 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045216.pdf [firstpage_image] =>[orig_patent_app_number] => 09879017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6047888 [patent_doc_number] => 20020168713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => '46980, a novel human neuroligin family member and uses thereof' [patent_app_type] => new [patent_app_number] => 09/875353 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 46879 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168713.pdf [firstpage_image] =>[orig_patent_app_number] => 09875353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6209028 [patent_doc_number] => 20020072090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'HR-1 RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/871617 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20104 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072090.pdf [firstpage_image] =>[orig_patent_app_number] => 09871617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1091751 [patent_doc_number] => 06824774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Antibodies that bind neuron restrictive silencer factor proteins' [patent_app_type] => B2 [patent_app_number] => 09/873155 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 14361 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824774.pdf [firstpage_image] =>[orig_patent_app_number] => 09873155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985700 [patent_doc_number] => 20020098491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Novel human semaphorin homologs and polynucleotides encoding the same' [patent_app_type] => new [patent_app_number] => 09/854845 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8927 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098491.pdf [firstpage_image] =>[orig_patent_app_number] => 09854845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157917 [patent_doc_number] => 20020146819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Human TSLP DNA and polypeptides' [patent_app_type] => new [patent_app_number] => 09/852391 [patent_app_country] => US [patent_app_date] => 2001-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21409 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146819.pdf [firstpage_image] =>[orig_patent_app_number] => 09852391 [rel_patent_id] =>[rel_patent_doc_number] =>)